Femme Homme
- | Pays :
- Canada
- United States
- Poland
- Les 5 autres...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this trial is to study the efficacy of a 35 mg delayed release weekly dosing regimen as compared to the standard daily dosing regimen of risedronate 5 mg daily.
Critère d'inclusion
- Postmenopausal osteoporosis